The Virginia Center for Health Innovation (VCHI) is receiving a $2.2 million grant from Arnold Ventures to launch a 3-year statewide pilot to reduce the use of low-value care in the state of Virginia.
As the conversation around the use of unnecessary medical services that increase both costs and potential patient harm continues, Virginia is taking steps to tackle low-value care. The Virginia Center for Health Innovation (VCHI) is receiving a $2.2 million grant from Arnold Ventures to launch a 3-year statewide pilot to reduce the use of low-value care in the Commonwealth, announced Daniel Carey, MD, the Virginia secretary of health and human services, at the University of Michigan’s Value-Based Insurance Design Summit.
VCHI will work with 6 Virginia health systems and 3 clinically integrated networks to form a large-scale health system learning community targeting 7 low-value care measures.
Virginia and VCHI have been identifying, measuring, and reporting on the use of unnecessary and low-value medical services, and found that, in 2017, 2.07 million unnecessary services cost $747 million.
“This pilot will take us on the next step…on our journey from our previous work,” Carey said. The plan is to create more available resources for high-value care by eliminating low-value care, he added.
The pilot will focus on reducing provider-driven sources of low-value care, such as unnecessary diagnostic and imaging services for low-risk patients before low-risk surgery. Each of the participating health systems has committed to establishing a leadership team, and they will be receiving quarterly reports from the Virginia All-Payer Claims Database and Milliman on how every clinician in the system performs on the 7 measures.
“What they do with it is up to them,” said Beth Bortz, president and chief executive officer of VCHI, but VCHI will track what they do and how they differ in their approaches of responding to the information.
In addition to partnering with the physicians, the pilot includes the launch of an employer task force with the goal of increasing employer knowledge and engaging them in actions they can take in employer communication, benefit design, and more, explained Bortz. The task force will include employers, the Virginia Chamber of Commerce, and the Virginia Business Coalition.
According to Bortz, VCHI felt it was important that at the same time the provider community works to drive down low-value care, that the employer community supports that work.
“We get started as of tomorrow,” Bortz said. “And by next year, hopefully, we’ll have some exciting results to share with you.”
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More